A reporter system for Epstein-Barr virus (EBV) lytic replication: Anti-EBV activity of the broad anti-herpesviral drug artesunate

Journal of Virological Methods

Volumn 173, Issue 2, 2011, Pages 334-339

  Auerochs, Sabrina ^a   Korn, Klaus ^a   Marschall, Manfred ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Anti herpesviral drug artesunate; Epstein Barr virus; GFP based reporter construct; Inhibition of lytic EBV replication; OriLyt dependent reporter expression

Indexed keywords

ARTESUNATE; GREEN FLUORESCENT PROTEIN;

ANTIVIRAL ACTIVITY; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CELL CLONE; CONTROLLED STUDY; DNA REPLICATION; DRUG MECHANISM; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE CONSTRUCT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REPLICON; REPORTER GENE; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS STRAIN;

ANTIVIRAL AGENTS; ARTEMISININS; BIOLOGICAL ASSAY; CELL LINE; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HERPESVIRUS 4, HUMAN; HUMANS; MICROBIAL SENSITIVITY TESTS; STAINING AND LABELING; T-LYMPHOCYTES; VIRUS REPLICATION;

ARTESUNATE; HUMAN HERPESVIRUS 4;

EID: 79954579924     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.03.005     Document Type: Article

References (18)

1. Billaud G., Thouvenot D., Morfin F. Drug targets in herpes simplex and Epstein Barr Virus infections. Infect. Disord. Drug Targets 2009, 9:117-125.
2. Chen C., Li D., Guo N. Regulation of cellular and viral protein expression by the Epstein-Barr virus transcriptional regulator Zta: implications for therapy of EBV associated tumors. Cancer Biol. Ther. 2009, 8:987-995.
3. Delecluse H.J., Hilsendegen T., Pich D., Zeidler R., Hammerschmidt W. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:8245-8250.
4. Efferth T., Marschall M., Wang X., Huong S.M., Hauber I., Olbrich A., Kronschnabl M., Stamminger T., Huang E.S. Antiviral activity of artesunate towards wild-type, recombinant and ganciclovir-resistant human cytomegaloviruses. J. Mol. Med. 2002, 80:233-242.
5. Efferth T., Romero M.R., Wolf D.G., Stamminger T., Marin J.J.G., Marschall M. The antiviral activities of artemisinin and artesunate. Clin. Infect. Dis. 2008, 47:804-811.
6. El-Guindy A., Heston L., Delecluse H.J., Miller G. Phosphoacceptor site S173 in the regulatory domain of Epstein-Barr Virus ZEBRA protein is required for lytic DNA replication but not for activation of viral early genes. J. Virol. 2007, 81:3303-3316.
7. Gruffat H., Batisse J., Pich D., Neuhierl B., Manet E., Hammerschmidt W., Sergeant A. Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus. J. Virol. 2002, 76:9635-9644.
8. Kieff E.D., Rickinson A.B. Epstein-Barr virus and its replication. Fields Virology 2007, 2603-2654. Lippincott Williams and Wilkins, Philadelphia. 5th ed. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus (Eds.).
9. Margolskee R.F., Kavathas P., Berg P. Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells. Mol. Cell. Biol. 1998, 8:2837-2847.
10. Marschall M., Alliger P., Schwarzmann F., Bogedain C., Brand M., Reichelt B., Glaser G., Wolf H. The lytic transition of Epstein-Barr virus is imitated by recombinant B-cells. Arch. Virol. 1993, 129:23-33.
11. Marschall M., Freitag M., Weiler S., Sorg G., Stamminger T. Recombinant GFP-expressing human cytomegalovirus as a tool for screening of antiviral agents. Antimicrob. Agents Chemother. 2000, 44:1588-1597.
12. Marschall M., Leser U., Seibl R., Wolf H. Identification of proteins encoded by Epstein-Barr viral trans-activator genes. J. Virol. 1989, 63:938-942.
13. Marschall M., Motz M., Leser U., Schwarzmann F., Oker B., Wolf H. Hepatitis B virus surface antigen as a reporter of promoter activity. Gene 1989, 81:109-117.
14. Marschall M., Stein-Gerlach M., Freitag M., Kupfer R., van den Bogaard M., Stamminger T. Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97. J. Gen. Virol. 2001, 82:1439-1450.
15. Milbradt J., Auerochs S., Korn K., Marschall M. Sensitivity of human herpesvirus 6 towards the broad-spectrum antiinfective drug artesunate. J. Clin. Virol. 2009, 46:24-28.
16. Plentz A., Jilg W., Kochanowski B., Ibach B., Knöll A. Detection of herpesvirus DNA in cerebrospinal fluid and correlation with clinical symptoms. Infection 2008, 36:158-162.
17. Rechter S., König T., Auerochs S., Thulke S., Dörnenburg H., Walter C., Marschall M. Antiviral activity of Arthrospira-derived spirulan-like substances. Antiviral Res. 2006, 7:197-206.
18. Yates J.L., Warren N., Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 1985, 313:812-815.